enGene Therapeutics (ENGN) vs Humacyte (HUMA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Humacyte (HUMA) has outperformed enGene Therapeutics (ENGN) over the past year, losing 71.3% versus a loss of 75.1%. Humacyte is the larger company by market cap ($131.2 million vs $116.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENGN | HUMA |
|---|---|---|
| Share price | $1.75 | $0.4723 |
| Market cap | $116.94M | $131.20M |
| 1-day change | -3.06% | -1.19% |
| YTD return | -80.68% | -50.85% |
| 1-year return | -75.11% | -71.29% |
| 5-year return | — | -95.38% |
| EPS (TTM) | $-2.07 | $-0.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.25 | $1.90 |
| 52-week low | $1.40 | $0.46 |
| Distance from 52-week high | -85.76% | -75.08% |
| Average volume | 759.27K | 6.35M |
| Shares outstanding | 67.02M | 277.80M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ENGN vs HUMA FAQ
Which is bigger, enGene Therapeutics or Humacyte?
Humacyte (HUMA) is larger, with a market capitalization of $131.20M compared with $116.94M for enGene Therapeutics (ENGN).
Which stock has performed better over the past year, ENGN or HUMA?
HUMA returned -71.29% over the past 12 months, compared with -75.11% for ENGN (price return, excluding dividends). Past performance does not predict future results.
Are enGene Therapeutics and Humacyte in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.